Abstract:In this work we disclose a new family of biscyclometallated Ir( III ) complexes of the general formula [Ir(C^N) 2 (N^N)]Cl ( IrL1–IrL5 ), where HC^N is 1-phenyl-β-carboline and N^N ligands ( L1–L5 ) are different diimine ligands that differ from each other in the number of aromatic rings fused to the bipyridine scaffold. The photophysical properties of IrL1–IrL5 were thoroughly studied, and theoretical calculations were performed for a deeper comprehension of the respective variations along the series. All complexes exhibited high photostability under blue light irradiation. An increase in the number of aromatic rings led to a reduction in the HOMO–LUMO band gap causing a red-shift in the absorbance bands. Although all the complexes generated singlet oxygen ( 1 O 2 ) in aerated aqueous solutions through a photocatalytic process, IrL5 was by far the most efficient photosensitizer. Consequently, IrL5 was highly active in the photocatalytic oxidation of NADH. The formation of aggregates in DMSO at a high concentration (25 mM) was confirmed using different techniques, but was proved to be negligible in the concentration range of biological experiments. Moreover, ICP-MS studies proved that the cellular uptake of IrL2 and IrL3 is much better relative to that of IrL1 , IrL4 and IrL5 . The antiproliferative activity of IrL1–IrL5 was investigated in the dark and under blue light irradiation against different cancer cell lines. Complexes IrL1–IrL4 were found to be cytotoxic under dark conditions, while IrL5 turned out to be weakly cytotoxic. Despite the low cellular uptake of IrL5 , this derivative exhibited a high increase of cytotoxicity upon blue light irradiation resulting in photocytotoxicity indexes (PI) up to 38. IrL1–IrL4 showed lower photocytotoxicity indexes ranging from 1.3 to 17.0. Haemolytic experiments corroborated the compatibility of our complexes with red blood cells. Confocal microscopy studies proved their accumulation in mitochondria, leading to mitochondrial membrane depolarization, and ruled out their localization in lysosomes. Overall, the mitochondria-targeted activity of IrL5 , which inhibits considerably the viability of cancer cells upon blue light irradiation, allows us to outline this PS as a new alternative to traditional chemotherapeutic agents.

AIE-active Ir(III) Complexes Functionalised with a Cationic Schiff Base Ligand: Synthesis, Photophysical Properties and Applications in Photodynamic Therapy.

AIE Multinuclear Ir(III) Complexes for Biocompatible Organic Nanoparticles with Highly Enhanced Photodynamic Performance

An AIE Metal Iridium Complex: Photophysical Properties and Singlet Oxygen Generation Capacity

Precise ligand engineering of Ir(III)-based photosensitizer with aggregation-induced emission for image-guided photodynamic therapy

AIE-active Iridium(iii) Complex Integrated with Upconversion Nanoparticles for NIR-irradiated Photodynamic Therapy.

Self-assembled Nanoparticles Based on Cationic Mono-/Aie Tetra-Nuclear Ir(III) Complexes: Long Wavelength Absorption/near-Infrared Emission Photosensitizers for Photodynamic Therapy.

Mixed-ligand iridium(iii) complexes as photodynamic anticancer agents.

Near-Infrared-Emitting Aie Multinuclear Cationic Ir(Iii) Complex-Assembled Nanoparticles For Photodynamic Therapy

Disulfide-Bridged Cationic Dinuclear Ir(III) Complex with Aggregation-Induced Emission and Glutathione-Consumption Properties for Elevating Photodynamic Therapy

AIPE-Active Ir(III) Complexes with Tuneable Photophysical Properties and Application in Mitochondria-Targeted Dual-Mode Photodynamic Therapy.

Rational design of iridium-porphyrin conjugates for novel synergistic photodynamic and photothermal therapy anticancer agents

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Recent Advances of Transition Ir(III) Complexes As Photosensitizers for Improved Photodynamic Therapy

A Cyclometallated Iridium(iii) Complex with Multi-Photon Absorption Properties As an Imaging-Guided Photosensitizer.

Ir(III) Half-Sandwich Photosensitizers with a π-Expansive Ligand for Efficient Anticancer Photodynamic Therapy

Towards efficient Ir(iii) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands

Designing NIR AIEgens for lysosomes targeting and efficient photodynamic therapy of tumors

Bsa-Encapsulated Cyclometalated Iridium Complexes As Nano-Photosensitizers For Photodynamic Therapy Of Tumor Cells

Recent Molecular Design Strategies for Efficient Photodynamic Therapy and Its Synergistic Therapy Based on AIE Photosensitizers

Near-infrared AIEgens with high singlet-oxygen yields for mitochondria-specific imaging and antitumor photodynamic therapy

Supramolecular coordination complexes (SCCs) with aggregation-induced emission for in vitro photodynamic therapy